FDA Lists More Than 1,500 AI-Enabled Medical Devices as Oncology Applications Expand
oncodaily - The U.S. Food and Drug Administration (FDA) has listed more than 1,500 artificial intelligence-enabled medical devices authorized for marketing in the United States, reflecting the growing integration of AI across […]
AI Summary: The FDA catalogued more than 1,500 AI‑enabled medical devices, spurring criticism that most were cleared without direct evidence they improve patient outcomes. Regulators and clinicians face mounting calls for post‑market studies and transparency, balancing enthusiasm for AI innovation against the sober question: do these devices actually help patients?
Related Stories
AI flags thousands more at risk of sudden cardiac death than standard methods / 2 months
Independent study flags safety issues in ChatGPT Health triage / 6 months
Large study finds medical AI can repeat and amplify health misinformation / 6 months
FDA clears first AI sepsis early‑warning monitoring tool / 3 months
Generative AI decision support improves primary care clinician decisions in trial / 2 months
IRhythm discloses cybersecurity incident, launches investigation / 2 months
CMS and FDA launch faster Medicare coverage pathway for breakthrough devices / 4 months
StackHealth RSS
You can now follow topics by RSS - browse the complete list of topics, people, and organizations. Or, try Wildlife, Neuroscience, Olfaction, Corporate Takeover and look for the RSS link.
StackHealth Time Machine